obesity and type 2 diabetes, a disease burden which is already on the rise in sub-Saharan Africa. “HIV itself disrupts your metabolism, as do many of the antiretrovirals,” says Chandiwana.

Neurotech Pharma's cell therapy Encelto has become the first FDA-approved therapy for idiopathic macular telangiectasia type 2. Gilead's already dominant position in HIV PrEP could be extended if ...

According to the World Health Organization (WHO), around 491 million people between the ages of 15 and 49 have HIV type 2 – the form of the virus that mainly causes genital herpes – which is ...